Aigen Investment Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Aigen Investment Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,299	Closed	-$1.77M	–	1086
2023 Q4	$1.77M	Buy	9,299 +3,515	+61%	+$664K	0.32%	76
2023 Q3	$1.15M	Buy	5,784 +1,026	+22%	+$243K	0.22%	129
2023 Q2	$1.36M	Buy	+4,758	New	+$1.32M	0.2%	141
2023 Q1	–	Sell	-18,209	Closed	-$3.74M	–	873
2022 Q4	$3.74M	Buy	18,209 +8,535	+88%	+$2.16M	0.53%	50
2022 Q3	$2.69M	Buy	+9,674	New	+$2.46M	0.39%	71
2022 Q2	–	Sell	-2,758	Closed	-$572K	–	771
2022 Q1	$572K	Buy	+2,758	New	+$455K	0.1%	258
2021 Q4	–	Sell	-1,836	Closed	-$378K	–	1214
2021 Q3	$378K	Buy	+1,836	New	+$360K	0.07%	295

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aigen Investment Management's SWAV Position: Q1 2024 in Review

Aigen Investment Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 9,299 shares — an estimated $1.77M sold.

Aigen Investment Management first reported a position in SWAV in Q3 2021 and held it in 7 quarters. The position peaked at $3.74M in Q4 2022. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

Aigen Investment Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Aigen Investment Management sold 9,299 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $1.77M.
Aigen Investment Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Aigen Investment Management's Shockwave Medical, Inc. Common Stock position peaked at $3.74M in Q4 2022.
488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.